Reappointment of Dr. Abhinay Bollineni, Dr. Bhaskara Rao Bollineni and Ms. Dandamudi Anitha

November 04, 2026 To To The Corporate Relations Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroz Jeejeebhoy Towers, 25th Floor, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Bandra (East), Mumbai- 400001 Mumbai - 400 051 Scrip Code - 543308 Symbol - KIMS ISIN: INE967H01025 ISIN: INE967H01025 Dear Sir/Madam, Sub: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015- Re-appointment of Dr. Abhinay Bollineni as Director & CEO, Re-appointment of Dr. Bhaskara Rao Bollineni as Chairman & Managing Director and Re-appointment of Ms. Dandamudi Anitha as Whole-time Director of the Company . Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that based on the recommendation of the Nomination & Remuneration Committee, the Board of Directors of Krishna Institute of Medical Sciences Limited (“the Company”), at its meeting held today, i.e., November 04, 2026, , has approved the following: • Re-appointment of Dr. Abhinay Bollineni (DIN No. 01681273) as Director & CEO of the Company for a further term of 5 years. • Reappointment of Dr. Bhaskara Rao Bollineni (DIN No. 00008985) as Chairman & Managing Director of the Company for a further term of five years, including continuation in office beyond the age of 70 years. • Reappointment of Ms. Dandamudi Anitha (DIN No. 00025480) as Whole-time Director of the Company for a term of 5 years. The requisite disclosure as per SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure-A to this letter. Board Meeting Commenced at : 02.00 P.M. Board Meeting Concluded at : 06:00 P.M. The same is also uploaded on the Company’s website at: https://www.kimshospitals.com /investors/ > Disclosures under Regulation 62 of the SEBI (LODR) Regulations, 2015 > Intimations filed by the Company > Intimations under Regulation 30. This is for your information and records. Thanking you, For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary & Compliance Officer Annexure-A Sr. Particulars Description 1. Reason for change viz. Re-appointment of Dr. Re-appointment of Dr. Re-appointment of Ms. appointment, re- Abhinay Bollineni Bhaskara Rao Bollineni Dandamudi Anitha appointment, (DIN No. 01681273) as (DIN No. 00008985) as (DIN No. 00025480) as resignation, removal, Director & CEO of the Chairman & Managing Whole-time Director of death or otherwise Company for a further Director of the the Company for a term term of 5 years Company for a further of 5 years term of five years, including continuation in office beyond the age of 70 years 2. Date of appointment/re- With effect from 18th With effect from 01st With effect from 01st appointment/cessation January 2027 for a April 2027 for a period April 2027 for a period of (as applicable) & term period of 60 Months. of 60 Months. 60 Months. of appointment/re- appointment 3. Brief profile (in case of Dr. Abhinay Bollineni Dr. Bhaskar Rao Ms. Anitha Dandamudi appointment) is an Executive Bollineni is one of the is a Wholetime Director Director & CEO of the promoters of the of the Company. She Company. He holds a Company and has been holds a diploma in bachelor’s degree in associated with the business management medicine and a Company for more from the ICFAI bachelor’s degree in than 23 years. He has University and a surgery from Dr. NTR been instrumental in certification for the six- University of Health scripting the sigma green belt. She Sciences, Andhra phenomenal growth also holds certifications Pradesh (Faculty of and success of the for the auditing of Modern Medicine) Company. KIMS quality systems as per through Deccan Hospital is one of the ISO 9001-2000 and ISO College of Medical leading Healthcare 9004-2000, and has Sciences. Brand in Telangana completed a training and Andhra Pradesh program on internal He has been associated with a consistent track quality audit for the with the Company record of growth. NABH. She has over 17 since 2013 and has years of experience in been spear heading the healthcare industry, Strategy & Marketing having held various for the entire Group in positions with your 2015. Company He was appointed as CEO in the year 2019. He was named in Business World’s “BW 40 Under 40” list in 2019. Under his stewardship, KIMS Hospitals got successfully listed on the Stock Exchanges in India in 2021. 4. Disclosure of He is Son of Dr. B. He is the father of Dr. Nil relationships between Bhaskara Rao, CMD Abhinay Bollineni and directors (in case of and Brother of Mr Adwik Bollineni, appointment of a Adwik Bollineni, Executive Directors of director) Executive Director of the Company. the Company.